Dr. Weeks’ Comment: Remember the dentist or pediatrician warning you not to give your children tetracycline because it might mottle your kid’s teeth? Well that […]
An Old Antibiotic for Metastatic Bone Cancer Read More »
Dr. Weeks’ Comments: In a market situation, the patient should be advised and allowed to choose. But as Dr. Bach comments below: “….Normal markets wouldn’t
This “trap” is a “steal” at 50% off – but who is doing stealing? Read More »
Dr. Weeks’ Comment: Studies are showing that for early breast cancer patients, chemotherapy does more harm than good. Time to personalize cancer therapies. Corrective Cancer
Towards personalized therapy for people with cancer Read More »
Dr. Weeks’ Comment: Geldanamycin (GA) is a natural product produced by Streptomyces hygroscopicus which inhibits a heat shock protein (HSP90) . Hsp90 interacts with other
Heat shock protein and Cancer Read More »
Dr. Weeks’ Comment: My mentor and friend, Abram Hoffer, Ph.D., M.D. (1917-2009) who was responsible for the first double blind studies in psychiatry, eventually
Problems with Double Blinding and Placebo Controlling Read More »
Dr. Weeks’ Comment: The day that Albert Einstein feared may have finally arrived. Having coffee with friends. A day at the beach. Cheering
Einstein and Social Media Read More »
Dr. Weeks’ Comment: Here we have scientific evidence of how what Dr. Morgentaler calls “group think” (uncritical analysis and ignoring inconvenient data) has created
Prostate Cancer and Testosterone – questions persist Read More »
Dr. Michael Gerber, M.D. reviews a lecture I gave at the Nevada Medical Society in 2011. His article, reprinted below, appeared in Townsend Newsletter for
The Cordelia Effect in Corrective Cancer Care Read More »
Dr. Weeks’ Comment: If you are going to accept chemotherapy, why not stack the cards in favor of more benefit and less side-effects? This is
These simple things may help your chemotherapy work better Read More »
Dr. Weeks’ Comment: Hepatitis C is a bad illness and the new research has produced a potent breakthrough – worth $11 billion? – remains to
Hep C – the standard of care has improved! Read More »
